Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

An investigation of the inclusion of women in clinical trials using a public clinical trials registry

FY 2011-12

Summary
Previous research has shown that not enough women are included in clinical trials of new medications. This is a cause for concern for several reasons. Because women's bodies break down medications differently than men, the same drugs that are found to be safe and effective in men may not always be safe and effective for women. Also, women often live longer than men, and are more likely to suffer from other diseases and medical conditions; this means that women use more medications than men, so it is especially important that drugs are safe and effective for women. Some research shows that there are still not enough women included in medical studies relating to treatments for arthritis, heart conditions, and certain types of cancers. However, we do not have information on the overall status of women in clinical trials and what types of trials currently do not include enough women. This study will examine a public database called clinicaltrials.gov than includes information about over 100,000 drug studies from nearly 200 countries. I will use the information from this website to study how many women are included in clinical trials, and what types of studies tend to not have enough female participants. This is a very important study because both the government and industry spend a lot of money testing new medications and therapies, with the hope that everyone will benefit from the results that are generated. Getting more information on this topic will help to determine if and why there are not enough women involved in the testing of new medications and pave the way for future policies that can encourage the inclusion of women in the testing of new drugs.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
253439
Name
Roberts Jodie
Region
British Columbia; Alberta
Country
Canada; Canada
Orgtype
Research Institution; Institution Paid
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Canada Graduate Scholarships Master's Awards B
Projecttitle
An investigation of the inclusion of women in clinical trials using a public clinical trials registry
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clinical Trials; Gender/Sex Equality; Pharmacoepidemiology; Women'S Issues
Abstract
Previous research has shown that not enough women are included in clinical trials of new medications. This is a cause for concern for several reasons. Because women's bodies break down medications differently than men, the same drugs that are found to be safe and effective in men may not always be safe and effective for women. Also, women often live longer than men, and are more likely to suffer from other diseases and medical conditions; this means that women use more medications than men, so it is especially important that drugs are safe and effective for women. Some research shows that there are still not enough women included in medical studies relating to treatments for arthritis, heart conditions, and certain types of cancers. However, we do not have information on the overall status of women in clinical trials and what types of trials currently do not include enough women. This study will examine a public database called clinicaltrials.gov than includes information about over 100,000 drug studies from nearly 200 countries. I will use the information from this website to study how many women are included in clinical trials, and what types of studies tend to not have enough female participants. This is a very important study because both the government and industry spend a lot of money testing new medications and therapies, with the hope that everyone will benefit from the results that are generated. Getting more information on this topic will help to determine if and why there are not enough women involved in the testing of new medications and pave the way for future policies that can encourage the inclusion of women in the testing of new drugs.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Roberts, Jodie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~